Back to Search Start Over

Bausch will test FDA waters in 2022 for dry eye disease drop after 2nd phase 3 confirms effect.

Authors :
LaHucik, Kyle
Source :
FierceBiotech; 9/30/2021, pN.PAG-N.PAG, 1p
Publication Year :
2021

Abstract

Patients with dry eye disease taking Bausch + Lomb and Novaliq's eye drop saw an improvement in the severity of eye dryness and damage to the eye during a phase 3 clinical trial. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
DRY eye syndromes
DROPLETS
CLINICAL trials

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
152789632

Tools

Authors Abstract Subjects Details